Trials / Completed
CompletedNCT02872129
12-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 126 (actual)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A 12-year follow-up of 166 women with fibromyalgia (FM) or chronic widespread pain (CWP) in western Sweden. The 166 women participated in a Randomised Controlled Trial called GAU in 2004-2005, aiming to investigate the effect of pool exercise and patient education. The primary aim of the present study is to examine the change of symptoms after 11-12 years in 166 women with FM or CWP and also investigate predictors of change of symptoms and work ability. The 166 women will be asked to participate in the present follow-up study. The follow-up examination comprises a standardised interview of symptoms and demographic variables, a battery of self-administered questionnaires and tests of physical function.
Detailed description
A 12-year follow-up of 166 women with fibromyalgia (FM) or chronic widespread pain (CWP). The 166 women participated in a Randomised Controlled Trial called GAU 2004-2005 in three cities in western Sweden; Göteborg, Alingsås and Uddevalla. The RCT aimed to investigate the effect of pool exercise and patient education. The primary aim of the present study is to examine the change of symptoms after 11-12 years in 166 women with FM or CWP and also investigate predictors of change of symptoms and work ability. The 166 women will be contacted by mail and telephone, and asked to participate in the present follow-up study. The follow-up examination comprises a standardised interview of symptoms and demographic variables, a battery of self-administered questionnaires and tests of physical function.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-08-19
- Last updated
- 2019-05-29
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02872129. Inclusion in this directory is not an endorsement.